{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:17:53Z","timestamp":1790983073445,"version":"4.1.0"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe the clinical management of heparin-induced thrombocytopenia with thrombosis (HITT) after orthopedic surgery and to highlight the role of clinical pharmacists in early recognition and individualized anticoagulant therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An 85-year-old woman developed HITT after right hip hemiarthroplasty and low molecular weight heparin thromboprophylaxis. Following the development of thrombocytopenia and new thrombotic events, clinical pharmacists participated in multidisciplinary evaluations, calculated the 4Ts score, recommended HIT antibody testing, and assisted in anticoagulant adjustment. Platelet count, D-dimer levels, renal function, and anti-PF4\/heparin antibody levels were monitored throughout hospitalization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The patient developed bilateral calf intermuscular venous thrombosis and multiple pulmonary emboli following orthopedic surgery. The 4Ts score was 6, and anti-PF4\/heparin antibody testing was positive (5.7\u2005U\/mL; reference range, 0\u20131.0\u2005U\/mL), confirming the diagnosis of HITT. Enoxaparin was discontinued, and anticoagulation was switched to fondaparinux sodium. Platelet counts gradually recovered from 27\u2009\u00d7\u200910\n                      <jats:sup>9<\/jats:sup>\n                      \/L to 253\u2009\u00d7\u200910\n                      <jats:sup>9<\/jats:sup>\n                      \/L during follow-up, with no recurrent thrombosis or bleeding events reported during the available follow-up period.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HITT after orthopedic surgery may be difficult to recognize because postoperative thrombocytopenia has multiple causes. This case highlights the importance of timely assessment of HIT probability and multidisciplinary collaboration. Clinical pharmacists may contribute to the early diagnosis, appropriate anticoagulant modification, and individualized management of patients with complex anticoagulation needs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1897675","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:25:07Z","timestamp":1785471907000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical pharmacist-guided management of heparin-induced thrombocytopenia with thrombosis after hip hemiarthroplasty: a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Qinan","family":"Yin","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhu","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Bian","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Song","sequence":"additional","affiliation":[{"name":"Clinical Trial Centre, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3760\/cma.j.cn112138-20240318-00176","article-title":"Research progresses on the pathogenesis and treatment of heparin-induced thrombocytopenia","volume":"63","author":"He","year":"2024","journal-title":"Chin J Intern Med"},{"key":"B2","first-page":"408","article-title":"Chinese expert consensus on heparin-induced thrombocytopenia (2017)","volume":"98","year":"2018","journal-title":"Chin Med J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"key":"B4","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.V96.5.1703","article-title":"Impact of the patient population on the risk for heparin-induced thrombocytopenia","volume":"96","author":"Warkentin","year":"2000","journal-title":"Blood."},{"key":"B5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.26574\/maedica.2022.17.2.513","article-title":"Lower limb paralysis as initial presentation of arterial embolism secondary to heparin-induced thrombocytopenia after hip fracture - a case report","volume":"17","author":"Kapsetakis","year":"2022","journal-title":"Maedica (Bucur)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3760\/cma.j.issn.0253-2352.2016.02.001","article-title":"Prevention of venous thromboembolism after major orthopaedic surgery","volume":"36","year":"2016","journal-title":"Chin J Orthop"},{"key":"B7","doi-asserted-by":"publisher","first-page":"824","DOI":"10.7754\/Clin.Lab.2021.210714","article-title":"Heparin-Induced thrombocytopenia caused by preventive anticoagulation after femoral intertrochanteric fracture surgery: a case report","volume":"68","author":"Hou","year":"2022","journal-title":"Clin Lab"},{"key":"B8","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3760\/cma.j.cn114452-20250418-00238","article-title":"Expert consensus on clinical monitoring of heparin drugs","volume":"48","year":"2025","journal-title":"Chin J Lab Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/ijlh.13564","article-title":"Diagnosing heparin-induced thrombocytopenia: the need for accuracy and speed","volume":"43","author":"Pishko","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/17474086.2021.1905512","article-title":"Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment","volume":"14","author":"Hvas","year":"2021","journal-title":"Expert Rev Hematol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1182\/hematology.2024000566","article-title":"Practical guide to the diagnosis and management of heparin-induced thrombocytopenia","volume":"2024","author":"May","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e584","DOI":"10.1093\/ajhp\/zxae109","article-title":"The efficacy and safety of direct oral anticoagulants in the treatment of the acute phase of heparin-induced thrombocytopenia: a systematic review","volume":"81","author":"Sadowski","year":"2024","journal-title":"Am J Health Syst Pharm"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1352982","DOI":"10.3389\/fphar.2024.1352982","article-title":"Unlocking the potential of fondaparinux: guideline for optimal usage and clinical suggestions","volume":"15","author":"Yin","year":"2024","journal-title":"Front Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev.med.042808.171814","article-title":"Heparin-induced thrombocytopenia","volume":"61","author":"Arepally","year":"2010","journal-title":"Annu Rev Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejvs.2020.09.023","article-title":"Editor's choice - European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis","volume":"61","author":"Kakkos","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B16","first-page":"1095","article-title":"New progress in laboratory testing of heparin-induced thrombocytopenia","volume":"48","author":"Chen","year":"2025","journal-title":"Chin J Lab Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3969\/j.issn.1000-3614.2018","article-title":"Interpretation of Chinese expert consensus on heparin-induced thrombocytopenia","volume":"33","author":"Xu","year":"2018","journal-title":"Chin Circ J"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1897675\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:25:10Z","timestamp":1785471910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1897675\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":17,"alternative-id":["10.3389\/fcvm.2026.1897675"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1897675","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"article-number":"1897675"}}